12-123688199-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024809.5(TCTN2):​c.891+22T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.447 in 1,590,942 control chromosomes in the GnomAD database, including 168,201 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 20487 hom., cov: 30)
Exomes 𝑓: 0.44 ( 147714 hom. )

Consequence

TCTN2
NM_024809.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.561

Publications

11 publications found
Variant links:
Genes affected
TCTN2 (HGNC:25774): (tectonic family member 2) This gene encodes a type I membrane protein that belongs to the tectonic family. Studies in mice suggest that this protein may be involved in hedgehog signaling, and essential for ciliogenesis. Mutations in this gene are associated with Meckel syndrome type 8. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
TCTN2 Gene-Disease associations (from GenCC):
  • Joubert syndrome 24
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-123688199-T-C is Benign according to our data. Variant chr12-123688199-T-C is described in ClinVar as [Benign]. Clinvar id is 126293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TCTN2NM_024809.5 linkc.891+22T>C intron_variant Intron 7 of 17 ENST00000303372.7 NP_079085.2 Q96GX1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TCTN2ENST00000303372.7 linkc.891+22T>C intron_variant Intron 7 of 17 1 NM_024809.5 ENSP00000304941.5 Q96GX1-1

Frequencies

GnomAD3 genomes
AF:
0.497
AC:
75254
AN:
151266
Hom.:
20442
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.721
Gnomad AMI
AF:
0.550
Gnomad AMR
AF:
0.382
Gnomad ASJ
AF:
0.395
Gnomad EAS
AF:
0.148
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.346
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.447
Gnomad OTH
AF:
0.464
GnomAD2 exomes
AF:
0.412
AC:
102436
AN:
248338
AF XY:
0.418
show subpopulations
Gnomad AFR exome
AF:
0.729
Gnomad AMR exome
AF:
0.266
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.153
Gnomad FIN exome
AF:
0.357
Gnomad NFE exome
AF:
0.446
Gnomad OTH exome
AF:
0.418
GnomAD4 exome
AF:
0.442
AC:
636453
AN:
1439566
Hom.:
147714
Cov.:
34
AF XY:
0.443
AC XY:
317895
AN XY:
717106
show subpopulations
African (AFR)
AF:
0.735
AC:
24058
AN:
32712
American (AMR)
AF:
0.279
AC:
12367
AN:
44330
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
9988
AN:
25854
East Asian (EAS)
AF:
0.120
AC:
4760
AN:
39544
South Asian (SAS)
AF:
0.491
AC:
41830
AN:
85276
European-Finnish (FIN)
AF:
0.354
AC:
18533
AN:
52334
Middle Eastern (MID)
AF:
0.440
AC:
2504
AN:
5694
European-Non Finnish (NFE)
AF:
0.453
AC:
496151
AN:
1094326
Other (OTH)
AF:
0.441
AC:
26262
AN:
59496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
15587
31175
46762
62350
77937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14690
29380
44070
58760
73450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.498
AC:
75347
AN:
151376
Hom.:
20487
Cov.:
30
AF XY:
0.490
AC XY:
36260
AN XY:
73938
show subpopulations
African (AFR)
AF:
0.721
AC:
29678
AN:
41158
American (AMR)
AF:
0.381
AC:
5807
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.395
AC:
1367
AN:
3464
East Asian (EAS)
AF:
0.148
AC:
763
AN:
5158
South Asian (SAS)
AF:
0.462
AC:
2223
AN:
4808
European-Finnish (FIN)
AF:
0.346
AC:
3609
AN:
10438
Middle Eastern (MID)
AF:
0.472
AC:
137
AN:
290
European-Non Finnish (NFE)
AF:
0.446
AC:
30288
AN:
67836
Other (OTH)
AF:
0.467
AC:
980
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1735
3471
5206
6942
8677
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.399
Hom.:
1993
Bravo
AF:
0.506
Asia WGS
AF:
0.347
AC:
1210
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Joubert syndrome 24 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meckel syndrome, type 8 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.17
DANN
Benign
0.40
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7302449; hg19: chr12-124172746; API